Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJin‐Kuk Kim, Timothy W. Yu, Chunguang Hu et al.|New England Journal of Medicine|2019Cited by 808
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Daniel E. Bauer, Anne H. Shen et al.|Nature Medicine|2019Cited by 518
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Alessandro Aiuti, Valeria Calbi et al.|The Lancet|2022Cited by 286
The Changing Face of AdrenoleukodystrophyJia Zhu, Joseph A. Majzoub, Florian Eichler et al.|Endocrine Reviews|2020Cited by 71
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug releaseMarco Peviani, Alessandra Biffi|Biomaterials|2019Cited by 57